Proto Labs INC Form 4 insider transactions

Proto Labs Inc. director Sven Wehrwein reported the sale of 2,000 shares of common stock in a recent SEC Form 4 filing.

Proto Labs Inc. President and CEO Suresh Krishna reported a sale of 1,247 shares of common stock on May 23, 2026, for $71.36 per share.

Proto Labs CFO Daniel Schumacher disposed of 255 shares of common stock to cover tax withholding obligations.

Chief Commercial Officer Bernardo Parlange acquired 2,109 restricted stock units and 3,789 stock options as part of an equity compensation award.

Proto Labs Inc. reports a Form 4 filing detailing a transaction by Director Chand Sujeet, acquiring 2,210 shares of common stock.

Proto Labs Director Rainer Gawlick acquired 2,210 shares of common stock.

Proto Labs Inc. reports that Director Sven Wehrwein acquired 2,210 shares of common stock on May 19, 2026.

Proto Labs Inc. Director Donald G. Krantz acquired 2,210 shares of common stock on May 19, 2026, as reported in a Form 4 filing.

Proto Labs Inc. reports that Chief Operations Officer Michael R. Kenison executed a series of stock transactions under a pre-arranged 10b5-1 plan.

Chief Operations Officer Michael R. Kenison exercised stock options and sold 200 shares of Proto Labs Inc. common stock.

Proto Labs Inc. CEO Suresh Krishna received 13,373 restricted stock units and 24,383 employee stock options.

Proto Labs Inc.'s Chief Financial Officer, Daniel Schumacher, acquired restricted stock units and stock options, while also disposing of shares to cover tax obligations.

Proto Labs' Chief Operations Officer, Michael R. Kenison, reported the acquisition of restricted stock units and employee stock options, alongside a disposition of shares for tax purposes.

Proto Labs' Chief Technology & AI Officer, Marc Kermisch, was granted 2,795 Restricted Stock Units and 5,095 employee stock options.

Proto Labs Chief Operations Officer Michael R. Kenison reported the disposition of 2,684 shares of common stock for tax liability.

Proto Labs' Chief Financial Officer, Daniel Schumacher, reported recent stock transactions including option exercises and tax-related share dispositions.

Proto Labs' Chief Operations Officer, Michael R. Kenison, sold 2,500 shares of common stock for $60 per share through a pre-arranged 10b5-1 trading plan.

Proto Labs' Chief Operations Officer, Michael R. Kenison, acquired 8,128 shares of common stock at a $0 price, increasing his direct beneficial ownership to 37,026 shares.

Proto Labs Inc.'s Chief Financial Officer, Daniel Schumacher, acquired 20,686 shares of common stock, increasing his beneficial ownership.

Proto Labs' Chief Operations Officer, Michael R. Kenison, filed an amended Form 4 to correct a clerical error regarding the expiration date of employee stock options, while also reporting recent stock transactions.

Proto Labs' Chief Operations Officer, Michael R. Kenison, exercised stock options and subsequently sold 3,048 shares of common stock under a pre-arranged 10b5-1 plan.

Proto Labs' Chief Technology & AI Officer, Marc Kermisch, acquired 3,718 restricted stock units and 6,818 employee stock options.

Proto Labs Inc. Director Rainer Gawlick acquired 1,715 shares of common stock at a weighted average price of $43.7928 per share on August 5, 2025.

Proto Labs Inc.'s President and CEO, Suresh Krishna, acquired 1,725 shares of common stock at an average price of $43.51 per share.

Proto Labs Inc. Director Archie C. Black has acquired 3,939 deferred stock units, increasing his total beneficial ownership to 26,218 shares of common stock.

Proto Labs Inc. Director Rainer Gawlick was granted 3,939 deferred stock units on May 23, 2025, increasing his beneficial ownership to 42,168 shares.

Proto Labs Inc. Director Moonhie Chin has acquired 3,939 shares of common stock through a deferred stock unit grant, increasing her total beneficial ownership to 20,096 shares.

Proto Labs Inc. Director Sujeet Chand was granted 3,939 deferred stock units, increasing his total beneficial ownership in the company to 24,653 shares.

Proto Labs Inc. Director Stacy Greiner reported the acquisition of 3,939 deferred stock units, increasing her beneficial ownership to 19,644 shares.

Proto Labs Inc. Director Sven Wehrwein has acquired 3,939 deferred stock units, increasing his beneficial ownership to 32,295 shares, as part of a compensation arrangement.